Salesforce (CRM) announced that Takeda has selected Salesforce Life Sciences Cloud for Customer Engagement to strengthen its ...

Salesforce (NYSE:CRM) announced a significant partnership with Takeda, selecting its Life Sciences Cloud for customer ...

Takeda Pharmaceuticals delivered strong FY2024 results and offers value with a 4.81% yield, despite pressure from Vyvanse ...

Those data centers that are equipped to handle AI processing loads are projected to require $5.2 trillion in capital ...

Dan Gandor, an omnichannel ace who has spent his entire career on the client side of the business, has joined Eversana ...

Salesforce (NYSE:CRM), the #1 AI CRM, today announced that Takeda has selected Salesforce Life Sciences Cloud for Customer Engagement to strengthen its involvement with healthcare professionals ...

Takeda has shot down candidates acquired in its $525 million Maverick Therapeutics takeover, blowing a hole in its oncology R ...

Protagonist Therapeutics, Inc. (”Protagonist” or the “Company”) today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will present a company overview at the Jefferies ...

1, Yealimi Noh, .79%. 2 (tie), Haeran Ryu and Rio Takeda, .78%. 4 (tie), Akie Iwai and Nanna Koerstz Madsen, .77%. 6 (tie), Allisen Corpuz and Hannah Green, .76%. 8, Lexi Thompson, .75%. 9, Rose Zhang ...

Takeda was scrambling to accommodate for rapidly sinking profits from the hasty decline of ADHD mainstay Vyvanse with a 140 ...

A research team at Mount Sinai have developed a risk score they found accurate in predicting Crohn’s disease in patients ...

Learn more about whether Alvotech or Arrowhead Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.